NGNitin Goyal

Nitin Goyal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nitin Goyal has a total of 575 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Superlarge-Bore Versus Large-Bore Aspiration Catheters in Mechanical Thrombectomy: A Multicenter Propensity-Matched Analysis

    by Ariana Chacon, Ali M. Alawieh, Mustafa Motiwala, Dareen Hijazi, Violiza Inoa, C. Michael Cawley, Brian M. Howard, Ansaar Rai, Fazeel Siddiqui, Ali Alaraj, et al.

    BACKGROUND AND OBJECTIVES: Aspiration catheters are an integral component of mechanical thrombectomy for acute ischemic stroke (AIS). Following early series demonstrating increasing procedural efficiency and improved outcomes with use of large-bore (LB) aspiration catheters, there is increased interest in the use of emerging superlarge-bore (SLB) catheters. METHODS: We retrospectively analyzed AIS patients with large vessel occlusion treated at 34 international centers (2018-2025) using SLB or LB aspiration catheters on the first attempt. We used propensity score matching (1:6) to define a balanced cohort based on baseline and technical confounders between the catheter groups. Safety, efficacy, and technical outcomes were compared, with the primary outcome being the first pass effect (FPE). RESULTS: A total of 2032 patients treated with aspiration as the frontline technique were included (SLB n = 107; LB n = 1925). After propensity score matching (SLB n = 107; LB n = 642), there was no significant difference in FPE between the SLB and LB groups (56.1% vs 54.8%; odds ratio [OR] 1.05, P = .8). Secondary efficacy outcomes were similarly comparable, including functional independence at 90 days (50.0% vs 46.9%; OR 1.13, P = .586), successful recanalization (modified thrombolysis in cerebral infarction ≥2b) (96.3% vs 93.5%; OR 1.78, P = .3), and median time to modified thrombolysis in cerebral infarction ≥2b (22.0 vs 22.8 minutes; β = −5.94, P = .7). Safety outcomes were also comparable, including intraprocedural complications (10.3% vs 8.2%, P = .5), symptomatic intracranial hemorrhage (8.7% vs 6.6%, P = .4), embolization to new territory (15.9% vs 13.1%, P = .4), and 90-day mortality (21.6% vs 27.1%, P = .3). Using a 10% noninferiority margin, LB aspiration catheters met the prespecified noninferiority criterion compared with SLB aspiration catheters for successful recanalization and FPE. Our findings remained consistent in the subgroup restricted to internal carotid artery and M1 occlusions. CONCLUSION: The use of SLB aspiration catheters showed comparable safety and efficacy with standard LB catheters for mechanical thrombectomy in AIS.

  • Open Access

    Early Reperfusion in Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment

    by Dylan N. Wolman, Rahul R. Karamchandani, Kwadwo Darko, Tyler M. Bielinski, Nitin Goyal, Jeremy B. Rhoten, Mahesh V. Jayaraman, Christian T. Sidebottom, Bradley A. Gross, Alhamza R. Al-Bayati, et al.

    BACKGROUND: Timely reperfusion is a critical determinant of favorable outcomes in basilar artery occlusion (BAO) stroke. We aimed to examine whether the choice of thrombolytic agent predicts early reperfusion (ER) in BAO stroke managed with tenecteplase versus alteplase before endovascular treatment. METHODS: This was a retrospective, multicenter US cohort of consecutive patients with BAO from 14 stroke centers treated with tenecteplase or alteplase within 4.5 hours of last known well before endovascular treatment. The primary end point was ER, defined as angiographic ER (expanded Thrombolysis in Cerebral Infarction grade 2b to 3 on the first diagnostic angiogram), or clinical ER, defined as substantial neurological improvement precluding endovascular treatment and a good functional outcome (modified Rankin Scale score 0–3). RESULTS: Among 163 patients with BAO and a median last known well-to-needle time of 135 minutes (interquartile range, 100–193) and last known well-to-puncture time of 228 minutes (interquartile range, 166–307), ER was observed in 27 (16.6%) patients. Rates of ER were comparable between tenecteplase (14/75, 18.7%) and alteplase (13/88, 14.8%; adjusted odds ratio, 1.082 [95% CI, 0.444–2.631]; P =0.862). In addition, rates of angiographic ER and clinical ER subgroups did not differ between thrombolytic agents. Higher Basilar Artery on Computed Tomography Angiography scores and a nonatherothrombotic cause independently predicted ER. In multivariable analysis, a good functional outcome was associated with younger age, lower stroke burden, and shorter last known well-to-puncture time. CONCLUSIONS: In BAO treated within 4.5 hours of last known well, tenecteplase and alteplase produced comparable early reperfusion rates. Achieving ER did not modify the association between thrombolytic agent and good functional outcome, consistent with rapid thrombectomy in patients with no ER.

  • Open Access

    Collateral status and outcomes in ICAS-LVO: insights from the RESCUE-ICAS registry

    by Mustafa Ismail, Ahmad Abu Qdais, Eyad Almallouhi, Adam De Havenon, Basem Zaino, Violiza Inoa, Francesco Capasso, Michael Nahhas, Robert M. Starke, Isabel Fragata, et al.

    Background: Collateral circulation influences outcomes in large-vessel occlusion (LVO) stroke, yet its modifying effect on endovascular therapy for intracranial atherosclerosis-related LVO (ICAS-LVO) remains uncertain. This study evaluated whether collateral status alters the association between stent-assisted thrombectomy and outcomes in anterior-circulation ICAS-LVO. Methods: An analysis was performed on 271 anterior-circulation ICAS-LVO patients from the RESCUE-ICAS registry. Collateral status was graded using the Tan collateral score (0–1 = poor, 2–3 = good). Patients were treated with mechanical thrombectomy (MT) alone or MT with adjunctive stenting. The primary outcome was functional independence (modified Rankin Scale [mRS] = 0–2) at 90 days. Secondary outcomes included successful reperfusion (mTICI≥2b), symptomatic intracranial hemorrhage (sICH), and mortality. Results: Among 271 patients, 172 (63.5% ) had good, and 99 (36.5%) had poor collaterals. In adjusted interaction models, stenting improved 90-day functional independence (aOR 3.22, p = 0.030) without significant stent–collateral interaction ( p = 0.876). No significant interactions were observed for mortality ( p = 0.847) or sICH ( p = 0.909). A significant adjusted interaction was present for final recanalization (interaction OR 8.35, p = 0.044). Conclusions: In anterior-circulation ICAS-LVO, adjunctive stenting was associated with improved functional outcomes across collateral strata, with collateral status showing some modification of the stent effect on angiographic success.

  • Open Access

    Final Infarct Volume as a Surrogate End Point in Anterior Circulation ICAS-LVO Stroke: Post Hoc Secondary Analysis of RESCUE-ICAS

    by Ahmad Abu Qdais, Mustafa Ismail, Ahmed Abdelwahab, Eyad Almallouhi, Shadi Yaghi, Violiza Inoa-Acosta, Francesco Capasso, Michael Nahhas, Robert M. Starke, Isabel Fragata, et al.

    BACKGROUND: Final infarct volume (FIV) on 24-hour magnetic resonance imaging is a well-established imaging biomarker linked to functional recovery after ischemic stroke, yet its prognostic value in intracranial atherosclerosis–related large vessel occlusion remains poorly explored. The impact of adjunct intracranial stenting on both infarct size and progression also remains unclear in this population. This study aimed to examine the association between FIV and clinical outcome, evaluate the effect of adjunct stenting on FIV and infarct progression, and assess the relationship between infarct progression and functional independence. METHODS: We conducted a post hoc secondary analysis of the RESCUE-ICAS registry (Registry of Emergent Large Vessel Occlusion due to Intracranial Stenosis); only patients with anterior circulation large vessel occlusion with magnetic resonance imaging after thrombectomy were included. FIV was measured on diffusion-weighted magnetic resonance imaging performed 24 to 36 hours postthrombectomy. Infarct progression was defined as the difference between baseline computed tomography perfusion infarct volume (cerebral blood flow P =0.007). Adjunct stenting was associated with a significant relative reduction in FIV, with inverse probability of treatment weighting–adjusted analyses demonstrating a 37.8% lower FIV compared with no stenting ( β =−0.47 [95% CI, −0.93 to −0.02]; P =0.043). Among 108 patients with baseline computed tomography perfusion data, infarct progression was strongly associated with outcome, with each additional 10 mL associated with ≈25% lower odds of achieving modified Rankin Scale score 0 to 2 at 90 days (adjusted odds ratio, 0.74 [95% CI, 0.60–0.90]; P =0.004), although infarct progression did not differ significantly between stented and nonstented groups (Δ −9.53 mL [95% CI −37.9 to 18.8]; P =0.506). In inverse probability of treatment weighting–weighted models adjusted for successful recanalization, stenting was not independently associated with reduced FIV ( β =−0.41; P =0.066), but remained independently associated with higher odds of 90-day functional independence (odds ratio, 2.29 [95% CI, 1.24–4.27]; P =0.008). CONCLUSIONS: Among intracranial atherosclerosis–related large vessel occlusion patients, 24- to 36-hour FIV is a strong predictor of functional outcome. Adjunct stenting is associated with smaller FIV. Lower infarct progression was also associated with favorable outcome. These findings highlight FIV as a reliable imaging biomarker and potential surrogate end point in future trials.

  • Open Access

    Effect of Acute Intracranial Stenting in Patients With Successful Reperfusion Following Large-Vessel Occlusion Secondary to Intracranial Atherosclerosis: Secondary Analyses of the RESCUE-ICAS Study

    by Sarah Nguyen, Adam de Havenon, Eyad Almallouhi, Mohammad A. Jumaa, Violiza Inoa, Francesco Capasso, Michael I. Nahhas, Robert M. Starke, Isabel Fragata, Matthew T. Bender, et al.

    BACKGROUND: The RESCUE-ICAS study (Registry of Emergent Large-Vessel Occlusion due to Intracranial Stenosis) demonstrated that patients undergoing acute stenting of intracranial atherosclerosis with large-vessel occlusion after mechanical thrombectomy had better outcomes than those undergoing mechanical thrombectomy alone. We present 2 secondary analyses of RESCUE-ICAS to evaluate intracranial stenting among patients who achieved successful reperfusion. METHODS: From a prospective observational cohort of 25 stroke centers (2022–2023), patients with acute intracranial occlusion, National Institutes of Health Stroke Scale score ≥6, and 50% to 99% residual stenosis or occlusion after endovascular thrombectomy were included. In the first analysis, we compared patients with stenting versus those without stenting from among those patients with a final modified Thrombolysis in Cerebral Infarction score of 2B–3. In the second analysis, we compared patients who underwent stenting with those who did not from among the patients with a Thrombolysis in Cerebral Infarction (TICI) score of 2B–3 before stenting. The odds of a favorable 90-day mRS (0–2) and 24-hour MRI infarct volume P =0.024). Patients who underwent stent placement were more likely to have 24-hour MRI infarct volume P =0.022). Our second analysis demonstrated that 89 patients who underwent acute intracranial stenting after successful perfusion (postmechanical thrombectomy) experienced higher odds of mRS scores of 0 to 2 at 90 days (adjusted odds ratio, 2.19 [95% CI, 1.01–4.74]) and 24-hour MRI infarct volume P =0.466) or death at 90 days (22.7% versus 25.9%; P =0.480). CONCLUSIONS: Among both the cohort with final successful reperfusion and the cohort with initial successful reperfusion after mechanical thrombectomy alone, intracranial stenting was associated with better long-term clinical and radiographic outcomes, without higher morbidity and mortality. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05403593.

  • Open Access

    First Line Thrombectomy Devices in Intracranial Atherosclerotic Disease: An analysis of the RESCUE-ICAS registry

    by Adam T Mierzwa, Ahmad abu Qdais, Imad Samman Tahhan, Shadi Yaghi, Violiza Inoa, Francesco Capasso, Michael Nahhas, Robert M. Starke, Isabel Fragata, Matthew Bender, et al.

    Introduction Managing atherosclerotic large vessel occlusion is procedurally challenging. Prior literature pertaining to technical considerations remain heterogenous and further research is necessary to highlight important differences. As such, first-line thrombectomy technique remains an active area of debate with respect to rate of recanalization, need for rescue stenting, and hemorrhagic complications. Methods This is a pre-planned analysis of the prospective RESCUE-ICAS registry which included atherosclerotic large vessel occlusions treated with mechanical thrombectomy from 25 sites. Patients were excluded if they had missing data on first-line technique or primary outcomes. Patients were dichotomized into two cohorts based on whether their first-line thrombectomy technique was with aspiration alone or a stentriever (SR). Primary procedural outcome was first-pass effect while primary safety outcome was mortality at 90 days. Propensity score matching and inverse probability weighted analysis were performed with respect to primary and secondary outcomes. Results 419 were patients included in this analysis with 266 and 153 patients in the aspiration and stentriever cohorts, respectively. The cohort’s mean age was 68 (SD ±13) years, and the majority of patients were white (59%) and male (62%). There were no significant baseline demographic differences between cohorts; however, ICA occlusions were more common in the stentriever cohort (52% vs 31%), while MCA occlusions were more frequent in the aspiration cohort (35% vs 15%). In the un-adjusted model, first pass effect was higher in stentriever versus aspiration (35.3% vs 23.7%, p = 0.01) with equivalent mortality rates (31% vs 26%, p = 0.31). Distal embolization rates were higher in the aspiration cohort (9.8% vs 3.9%, p = 0.03), yet aspiration was associated with lower composited procedural complications (6% vs 11%, p = 0.01). Propensity score matching and weighted analysis demonstrated that differences in primary clinical efficacy and safety outcomes were insignificant between cohorts. Conclusion In patients with atherosclerotic large vessel occlusions, first line stentriever utilization was associated with higher first-pass effect rates, lower rates of distal embolization and shorter procedural length compared to aspiration. However, no clinical outcome difference was appreciated between the two groups and aspiration was associated with lower complication rates.

  • Top Cited Papers
    Open Access

    The Added Benefit of Intra‐Arterial Thrombolysis After Successful Recanalization by Endovascular Treatment: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Clinical Trials

    by Lina Palaiodimou, Nikolaos M. Papageorgiou, Guillaume Turc, Benjamin Gory, Aikaterini Theodorou, Eleni Bakola, George Magoufis, Stavros Spiliopoulos, Michail Mantatzis, Nitin Goyal, et al.

    Background: Despite successful recanalization following endovascular thrombectomy (EVT) for acute ischemic stroke (AIS) with large‐vessel occlusion (LVO), many patients fail to achieve excellent functional outcomes. Post‐EVT intra‐arterial thrombolysis (IAT) has emerged as a potential adjunctive strategy to improve microvascular reperfusion and clinical recovery.Methods: We conducted a systematic review and meta‐analysis of randomized‐controlled clinical trials (RCTs) comparing IAT plus best medical therapy (BMT) versus BMT alone in LVO‐AIS patients with successful recanalization post‐EVT. The primary efficacy outcome was 3‐month excellent functional outcome [modified Rankin Scale (mRS)‐score: 0–1]. Secondary efficacy outcomes included good functional outcome (mRS‐score: 0–2) and reduced disability (mRS‐score shift analysis) at 3 months. The primary safety outcome was symptomatic intracranial hemorrhage (sICH); secondary safety outcomes included any‐ICH and 3‐month all‐cause mortality. Subgroup and network meta‐analyses were performed evaluating the effects of different thrombolytic agents.Results: Seven RCTs were included, comprising 1083 patients treated with IAT and 1048 patients treated with BMT alone. IAT was associated with higher likelihood of excellent functional outcome (RR: 1.23; 95% CI: 1.11–1.36; I2 = 0%) and reduced disability at 3 months (common‐OR: 1.10; 95% CI: 1.03–1.18; I2 = 0%) compared with BMT alone. Similar rates of 3‐month good functional outcome, 3‐month mortality, sICH and any‐ICH were observed. Although no significant subgroup differences emerged, in the network meta‐analysis alteplase ranked highest in efficacy [surface under the cumulative rank curve (SUCRA): 90%], followed by tenecteplase (61%) and urokinase (40%) in achieving 3‐month excellent functional outcome.Conclusions: IAT improves excellent functional outcomes without compromising safety in LVO‐AIS patients with successful recanalization after EVT.Trial Registration: The prespecified protocol of the present systematic review and meta‐analysis has been registered in the International Prospective Register of Ongoing Systematic Reviews PROSPERO (registration ID: CRD420251035903)


  • Open Access

    Embolization of Middle Meningeal Artery in Patients with Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis of Randomized-Controlled Clinical Trials

    by Nikolaos M. Papageorgiou, Lina Palaiodimou, Konstantinos Melanis, Aikaterini Theodorou, Maria-Ioanna Stefanou, Panagiota-Eleni Tsalouchidou, Pinelopi Vlotinou, Lampis C. Stavrinou, Efstathios Boviatsis, Georgios Magoufis, et al.

    Background: Chronic subdural hematoma (cSDH) is a common neurosurgical condition, particularly among elderly patients. Middle meningeal artery (MMA) embolization has emerged as a minimally invasive adjunctive treatment aimed at reducing recurrence. However, its comparative efficacy and safety remain under investigation. Methods: In this systematic review and meta-analysis, randomized-controlled clinical trial (RCT) data evaluating MMA embolization combined with best medical therapy (BMT) versus BMT alone in adult patients with symptomatic cSDH were pooled. The primary efficacy outcome was recurrence or progression of hematoma at follow-up. Secondary efficacy outcomes included good functional outcome [modified Rankin Scale (mRS) score ≤ 2], independent ambulation (mRS score ≤ 3), and hematoma thickness at follow-up. The primary safety outcome was all-cause mortality. Procedure-related complications were assessed as a secondary safety outcome. Results: Six RCTs were included, comprising 760 patients treated with MMA embolization and 788 patients treated with BMT alone. MMA embolization significantly reduced recurrence compared to BMT alone (RR: 0.50; 95% CI: 0.37–0.69; six studies; I2 = 0%; number-needed-to-treat = 13). No significant differences were observed in good functional outcome (RR: 1.01; 95% CI: 0.97–1.05; three studies; I2 = 0%), independent ambulation (RR: 1.01; 95% CI: 0.99–1.04; three studies; I2 = 0%), or hematoma thickness at follow-up (SMD: −0.1; 95% CI: −0.3 to 0; four studies; I2 = 42%). All-cause mortality was similar between the two groups (RR: 1.01; 95% CI: 0.42–2.40; five studies; I2 = 44%). The pooled rate of procedure-related adverse events in the MMA embolization-group was 1% (95% CI: 0–3%; two studies; I2 = 35%). Conclusions: MMA embolization significantly reduced cSDH recurrence when used as an adjunct to BMT. However, it did not demonstrate a significant impact on functional outcomes or mortality in this meta-analysis. Further research is needed to identify patient subgroups that benefit most from MMA embolization and to evaluate its impact on cognitive function and quality of life using longer follow-up periods.


  • Top Cited Papers

    Outcomes of Adjunct Emergent Stenting Versus Mechanical Thrombectomy Alone: The RESCUE-ICAS Registry

    by Sami Al Kasab, Eyad Almallouhi, Mohammad Jumaa, Violiza Inoa, Francesco Capasso, Michael Nahhas, Robert M. Starke, Isabel Fragata, Matthew Bender, Krisztina Moldovan, et al.

    BACKGROUND: Underlying intracranial stenosis is the most common cause of failed mechanical thrombectomy in patients with acute ischemic stroke with large vessel occlusion. Adjunct emergent stenting is sometimes performed to improve or maintain reperfusion, despite limited data regarding its safety or efficacy. METHODS: We conducted a prospective multicenter observational international cohort study. Patients were enrolled between January 2022 and December 2023 at 25 thrombectomy-capable centers in North America, Europe, and Asia. Consecutive patients treated with mechanical thrombectomy were included if they were identified as having underlying intracranial stenosis, defined as 50% to 99% residual stenosis of the target vessel or intraprocedural reocclusion. The primary outcome was functional independence, defined as a modified Rankin Scale score of 0 to 2 at 90 days. After applying inverse probability of treatment weighting based on propensity scores, we compared outcomes among patients who underwent adjunct emergent intracranial stenting (stenting) versus those who received mechanical thrombectomy alone. RESULTS: A total of 417 patients were included: 218 patients treated with mechanical thrombectomy alone (168 anterior circulation) and 199 with mechanical thrombectomy plus stenting (144 anterior circulation). Patients in the stenting group were less likely to be non-Hispanic White (51.8% versus 62.4%, P =0.03) and less likely to have diabetes (33.2% versus 43.1%, P =0.037) or hyperlipidemia (43.2% versus 56%, P =0.009). In addition, there was a lower rate of IV thrombolysis use in the stenting group (18.6% versus 27.5%, P =0.03). There was a higher rate of successful reperfusion (modified Treatment in Cerebral Infarction score ≥2B) in the stenting versus mechanical thrombectomy–alone group (90.9% versus 77.9%, P P =0.005). The overall complication rate was higher in the stenting group (12.6% versus 5%, P =0.006), but there was not a significant difference in the rate of symptomatic hemorrhage (9% versus 5.5%, P =0.162). Functional independence at 90 days was significantly higher in the stenting group (42.2% versus 28.4%, adjusted odds ratio, 2.67 [95% CI, 1.66–4.32]). CONCLUSIONS: In patients with underlying stenosis who achieved reperfusion with mechanical thrombectomy, adjunct emergent stenting was associated with better functional outcome without a significantly increased risk of symptomatic hemorrhage. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05403593.


  • Middle meningeal artery embolization with standalone or adjunctive coiling for treatment of chronic subdural hematoma: Systematic review and meta-analysis

    by Haydn Hoffman, Jason J. Sims, Christopher Nickele, Violiza Inoa, Lucas Elijovich, Nitin Goyal

    Introduction: Middle meningeal artery embolization (MMAe) is increasingly utilized as a primary or secondary treatment for chronic subdural hematoma (cSDH) and is usually performed with liquid embolics or particles. Outcomes after MMAe with coiling as a standalone treatment, or an adjunct to other agents, have not been reviewed. Methods: A systematic review of the literature was performed to identify all original research that included patients who underwent standalone or adjunctive coiling for MMAe. The primary outcome was the need for rescue treatment defined as any unplanned reintervention for recurrent or residual cSDH. Results: A total of 10 studies comprising 346 patients (mean age 73 years, 39% female) who underwent MMAe with coils were included. The majority of embolizations were with coils and particles ( n = 176), followed by standalone coiling (137) and coiling with liquid embolics (120). The pooled rate of rescue treatment after embolization was 9.4% (95% CI 6.4–13.6, I2 = 0). The pooled complication rate was 2.6% (95% CI 1.3–5.1, I2 = 0). In the subgroup analysis of four studies reporting results after standalone coiling, the pooled rescue treatment rate was 8.2% (95% CI 4.0–15.9, I2 = 0) and there were no complications. Conclusion: MMAe with coils is safe and potentially effective, but additional studies evaluating long-term clinical and radiographic results after standalone coiling are needed.